Modulation of collagen gene expression: Its relation to fibrosis in systemic sclerosis and other disorders

J. Varga*, S. A. Jimenez

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

54 Scopus citations


Fibrosis is the pathologic hallmark of many common diseases. Much information has recently emerged about the cellular and biochemical events that result in its development and progression. It is now known that in affected tissues, chronic inflammation generally precedes fibrosis and that inflammatory cell-derived cytokines are crucial mediators of fibrogenesis. Several cytokines have been identified that influence wound healing and tissue repair processes in vivo and that modulate the production of collagen in vitro. Of these, transforming growth factor-β is of the most interest because this pleiotropic cytokine is expressed at high levels during tissue remodelling and greatly affects the formation of connective tissue. Furthermore, it has been recently shown that transforming growth factor-β can stimulate the transcription of collagen genes through the production or activation of specific DNA-binding trans-acting factors. A precise understanding of the molecular mechanisms responsible for the effects of this cytokine on collagen gene expression may allow the design of selective therapeutic interventions aimed at retarding or preventing the development of fibrosis.

Original languageEnglish (US)
Pages (from-to)60-62
Number of pages3
JournalAnnals of internal medicine
Issue number1
StatePublished - 1995

ASJC Scopus subject areas

  • Internal Medicine


Dive into the research topics of 'Modulation of collagen gene expression: Its relation to fibrosis in systemic sclerosis and other disorders'. Together they form a unique fingerprint.

Cite this